Detalhe da pesquisa
1.
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.
Blood
; 139(13): 1999-2010, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780623
2.
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant.
Blood
; 139(11): 1670-1683, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871371
3.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
4.
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
Blood
; 140(2): 112-120, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427411
5.
Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.
Immunity
; 42(1): 186-98, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25607463
6.
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Blood
; 138(26): 2810-2827, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407545
7.
Determining subpopulation methylation profiles from bisulfite sequencing data of heterogeneous samples using DXM.
Nucleic Acids Res
; 49(16): e93, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157105
8.
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Br J Haematol
; 197(2): 212-222, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106754
9.
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
N Engl J Med
; 381(5): 432-443, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31365801
10.
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.
Blood
; 136(20): 2308-2318, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614951
11.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol
; 195(5): 757-763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581433
12.
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 26(12): 2223-2228, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829079
13.
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.
Blood
; 132(23): 2446-2455, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287523
14.
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Blood
; 131(23): 2515-2527, 2018 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463563
15.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
N Engl J Med
; 375(21): 2023-2036, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959731
16.
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
Blood
; 129(19): 2680-2692, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292947
17.
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
Blood
; 129(4): 473-483, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28064239
18.
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Haematologica
; 109(3): 953-957, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706336
19.
Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection.
Biol Blood Marrow Transplant
; 23(8): 1282-1289, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476490
20.
Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(12): 2199-2204, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28847710